The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Wnt signaling in bone formation and its therapeutic potential for bone diseases
Open accessAbstract
The Wnt signaling pathway plays an important role not only in embryonic development but also in the maintenance and differentiation of the stem cells in adulthood. In particular, Wnt signaling has been shown as an important regulatory pathway in the osteogenic differentiation of mesenchymal stem cells. Induction of the Wnt signaling pathway promotes bone formation while inactivation of the pathway leads to osteopenic states. Our current understanding of Wnt signaling in osteogenesis elucidates the molecular mechanisms of classic osteogenic pathologies. Activating and inactivating aberrations of the canonical Wnt signaling pathway in osteogenesis results in sclerosteosis and osteoporosis respectively. Recent studies have sought to target the Wnt signaling pathway to treat osteogenic disorders. Potential therapeutic approaches attempt to stimulate the Wnt signaling pathway by upregulating the intracellular mediators of the Wnt signaling cascade and inhibiting the endogenous antagonists of the pathway. Antibodies against endogenous antagonists, such as sclerostin and dickkopf-1, have demonstrated promising results in promoting bone formation and fracture healing. Lithium, an inhibitor of glycogen synthase kinase 3β, has also been reported to stimulate osteogenesis by stabilizing β catenin. Although manipulating the Wnt signaling pathway has abundant therapeutic potential, it requires cautious approach due to risks of tumorigenesis. The present review discusses the role of the Wnt signaling pathway in osteogenesis and examines its targeted therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Takada, I., Mihara, M., Suzawa, M., Ohtake, F., Kobayashi, S., Igarashi, M., Youn, M.-Y., Takeyama, K.-I., Nakamura, T., Mezaki, Y., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1647 · Cited by 424
RetractedWnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696 · cited 1×
“Other potential therapeutic targets are also currently undergoing preclinical investigation [Rachner et al. 2011].”
BackgroundIdentification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,355
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Mutations of Chromosome 5q21 Genes in FAP and Colorectal Cancer Patients
Nishisho, I., Nakamura, Y., Miyoshi, Y., Miki, Y., Ando, H., Horii, A., Koyama, K., Utsunomiya, J., Baba, S., Hedge, P., et al. (1991) · Science · doi:10.1126/science.1651563 · Cited by 1,892
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
TGF-β and BMP Signaling in Osteoblast Differentiation and Bone Formation
Chen, G., Deng, C., & Li, Y.-P. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.2929 · Cited by 1,756 · cited 1×
“For example, bone morphogenic proteins (BMPs) have been shown to either enhance or antagonize the osteogenic differentiation induced by Wnt signaling [Chen et al. 2012; Lin and Hankenson, 2011].”
Mesenchymal Stem Cells: Revisiting History, Concepts, and Assays
Bianco, P., Robey, P. G., & Simmons, P. J. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.03.002 · Cited by 1,621
Day, T. F., Guo, X., Garrett-Beal, L., & Yang, Y. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.03.016 · Cited by 1,616
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Secreted antagonists of the Wnt signalling pathway
Kawano, Y., & Kypta, R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00623 · Cited by 1,584
Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass, D. A., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H., Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.017 · Cited by 1,558
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Regulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407 · cited 1×
“Nonetheless, it is relatively well established that the Wnt signaling pathway plays an important role in promoting the osteogenic differentiation of MSCs [Cawthorne et al. 2012; Krishnan et al. 2006].”
BackgroundSclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366 · cited 1×
“For example, sclerostin binds the coreceptor LRP5/6 to competitively inhibit the binding of Wnt ligands to LRP5/6 [Li et al. 2005; Semënov et al. 2005].”
BackgroundSelf-citationDickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
Mikels, A. J., & Nusse, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040115 · Cited by 1,252
Association of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223
Canonical WNT Signaling Promotes Osteogenesis by Directly Stimulating Runx2 Gene Expression
Gaur, T., Lengner, C. J., Hovhannisyan, H., Bhat, R. A., Bodine, P. V. N., Komm, B. S., Javed, A., van Wijnen, A. J., Stein, J. L., Stein, G. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500608200 · Cited by 1,170
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147 · cited 1×
“Mutations within the SOST gene were shown to be responsible for sclerosteosis [Balemans et al. 2001], whereas van Buchem’s disease is associated with a 52 kb deletion in the noncoding region containing the enhancer element of SOST [Balemans et al.”
BackgroundOsteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086 · cited 1×
“Inactivating mutations of LRP5 in mice recapitulated the phenotypes of OPPG in human patients [Cui et al. 2011; Kato et al. 2002], and LRP5 knockout resulted in impaired fracture healing in comparison to wildtype mice [Komatsu et al.”
BackgroundAn LDL-receptor-related protein mediates Wnt signalling in mice
Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., & Skarnes, W. C. (2000) · Nature · doi:10.1038/35035124 · Cited by 1,086
Canonical Wnt/β-Catenin Signaling Prevents Osteoblasts from Differentiating into Chondrocytes
Hill, T. P., Später, D., Taketo, M. M., Birchmeier, W., & Hartmann, C. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.02.013 · Cited by 1,084
Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling
Mao, B., Wu, W., Davidson, G., Marhold, J., Li, M., Mechler, B. M., Delius, H., Hoppe, D., Stannek, P., Walter, C., et al. (2002) · Nature · doi:10.1038/nature756 · Cited by 1,038
Rodda, S. J., & McMahon, A. P. (2006) · Development · doi:10.1242/dev.02480 · Cited by 1,010
Li, X., Ominsky, M. S., Niu, Q.-T., Sun, N., Daugherty, B., D'Agostin, D., Kurahara, C., Gao, Y., Cao, J., Gong, J., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080216 · Cited by 936
Regulation of osteoblastogenesis and bone mass by Wnt10b
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D., & MacDougald, O. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408742102 · Cited by 881
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847 · cited 1×
“com fact, these oncogenic risks have been well documented with mutations of Wnt signaling mediators such as APC, Axin, GSK3β, β catenin and LRP [Polakis, 2012].”
BackgroundSingle-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
Padhi, D., Jang, G., Stouch, B., Fang, L., & Posvar, E. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.173 · Cited by 786
Li, X., Ominsky, M. S., Warmington, K. S., Morony, S., Gong, J., Cao, J., Gao, Y., Shalhoub, V., Tipton, B., Haldankar, R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081206 · Cited by 784
Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor
Semënov, M., Tamai, K., & He, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504308200 · Cited by 771
BMP-2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop
Rawadi, G., Vayssière, B., Dunn, F., Baron, R., & Roman-Roman, S. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1842 · Cited by 764
A new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750 · cited 1×
“Meanwhile, SFRPs and Wif-1 directly bind Wnt ligands to prevent their binding to Fzd and LRP5/6 [Hsieh et al. 1999; Kawano and Kypta, 2003].”
BackgroundIdentification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Mutations in AXIN2 Cause Familial Tooth Agenesis and Predispose to Colorectal Cancer
Lammi, L., Arte, S., Somer, M., Järvinen, H., Lahermo, P., Thesleff, I., Pirinen, S., & Nieminen, P. (2004) · The American Journal of Human Genetics · doi:10.1086/386293 · Cited by 691
An Updated Overview on Wnt Signaling Pathways: A Prelude for More
Rao, T. P., & Kühl, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.219840 · Cited by 638
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · cited 1×
“GSK3β, axin and APC form the degradation complex which tags β catenin for degradation in the inactive state [Kimelman and Xu, 2006].”
BackgroundGurney, A., Axelrod, F., Bond, C. J., Cain, J., Chartier, C., Donigan, L., Fischer, M., Chaudhari, A., Ji, M., Kapoun, A. M., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120068109 · Cited by 614
A common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612
LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors
Mani, A., Radhakrishnan, J., Wang, H., Mani, A., Mani, M.-A., Nelson-Williams, C., Carew, K. S., Mane, S., Najmabadi, H., Wu, D., et al. (2007) · Science · doi:10.1126/science.1136370 · Cited by 588
Essential role of β-catenin in postnatal bone acquisition.
Holmen, S. L., Zylstra, C. R., Mukherjee, A., Sigler, R. E., Faugere, M.-C., Bouxsein, M. L., Deng, L., Clemens, T. L., & Williams, B. O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501900200 · Cited by 584 · cited 2×
“APC deletion in osteoblasts led to increased bone mass through overactivating the β-catenindependent Wnt signaling [Holmen et al. 2005].”
BackgroundLuu, H. H., Song, W., Luo, X., Manning, D., Luo, J., Deng, Z., Sharff, K. A., Montag, A. G., Haydon, R. C., & He, T. (2007) · Journal of Orthopaedic Research · doi:10.1002/jor.20359 · Cited by 545
Self-citationDeletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Wnt/Ca2+ signaling pathway: a brief overview
De, A. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr079 · Cited by 523
Clément-Lacroix, P., Ai, M., Morvan, F., Roman-Roman, S., Vayssière, B., Belleville, C., Estrera, K., Warman, M. L., Baron, R., & Rawadi, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505259102 · Cited by 520
Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation
Lin, G. L., & Hankenson, K. D. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23287 · Cited by 510
High Bone Mass in Mice Expressing a Mutant LRP5 Gene
Babij, P., Zhao, W., Small, C., Kharode, Y., Yaworsky, P. J., Bouxsein, M. L., Reddy, P. S., Bodine, P. V., Robinson, J. A., Bhat, B., et al. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.960 · Cited by 497
A Member of the Frizzled Protein Family Mediating Axis Induction by Wnt-5A
He, X., Saint-Jeannet, J.-P., Wang, Y., Nathans, J., Dawid, I., & Varmus, H. (1997) · Science · doi:10.1126/science.275.5306.1652 · Cited by 492
Zhu, M., Tang, D., Wu, Q., Hao, S., Chen, M., Xie, C., Rosier, R. N., O'Keefe, R. J., Zuscik, M., & Chen, D. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080901 · Cited by 476
Lrp5 functions in bone to regulate bone mass
Cui, Y., Niziolek, P. J., MacDonald, B. T., Zylstra, C. R., Alenina, N., Robinson, D. R., Zhong, Z., Matthes, S., Jacobsen, C. M., Conlon, R. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2388 · Cited by 453
Bodine, P. V. N., Zhao, W., Kharode, Y. P., Bex, F. J., Lambert, A.-J., Goad, M. B., Gaur, T., Stein, G. S., Lian, J. B., & Komm, B. S. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0498 · Cited by 449
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
Loots, G. G., Kneissel, M., Keller, H., Baptist, M., Chang, J., Collette, N. M., Ovcharenko, D., Plajzer-Frick, I., & Rubin, E. M. (2005) · Genome Research · doi:10.1101/gr.3437105 · Cited by 442 · cited 1×
“2001], whereas van Buchem’s disease is associated with a 52 kb deletion in the noncoding region containing the enhancer element of SOST [Balemans et al. 2002; Loots et al. 2005].”
BackgroundDkk1-mediated inhibition of Wnt signaling in bone results in osteopenia
Li, J., Sarosi, I., Cattley, R. C., Pretorius, J., Asuncion, F., Grisanti, M., Morony, S., Adamu, S., Geng, Z., Qiu, W., et al. (2006) · Bone · doi:10.1016/j.bone.2006.03.017 · Cited by 441
Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B., & Shaughnessy, J. D. (2007) · Blood · doi:10.1182/blood-2006-09-047712 · Cited by 433
Cawthorn, W. P., Bree, A. J., Yao, Y., Du, B., Hemati, N., Martinez-Santibañez, G., & MacDougald, O. A. (2012) · Bone · doi:10.1016/j.bone.2011.08.010 · Cited by 415
Ominsky, M. S., Vlasseros, F., Jolette, J., Smith, S. Y., Stouch, B., Doellgast, G., Gong, J., Gao, Y., Cao, J., Graham, K., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.14 · Cited by 414
Kang, S., Bennett, C. N., Gerin, I., Rapp, L. A., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700030200 · Cited by 401
Alternative Wnt Signaling Is Initiated by Distinct Receptors
van Amerongen, R., Mikels, A., & Nusse, R. (2008) · Science Signaling · doi:10.1126/scisignal.135re9 · Cited by 401
Loughlin, J., Dowling, B., Chapman, K., Marcelline, L., Mustafa, Z., Southam, L., Ferreira, A., Ciesielski, C., Carson, D. A., & Corr, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403456101 · Cited by 400
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Fulciniti, M., Tassone, P., Hideshima, T., Vallet, S., Nanjappa, P., Ettenberg, S. A., Shen, Z., Patel, N., Tai, Y.-T., Chauhan, D., et al. (2009) · Blood · doi:10.1182/blood-2008-11-191577 · Cited by 399
Update on Wnt signaling in bone cell biology and bone disease
Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J., & Westendorf, J. J. (2012) · Gene · doi:10.1016/j.gene.2011.10.044 · Cited by 392
Chen, Y., Whetstone, H. C., Lin, A. C., Nadesan, P., Wei, Q., Poon, R., & Alman, B. A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040249 · Cited by 391
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
Bezooijen, R. L. V., Dijke, P. T., Papapoulos, S. E., & G.M. Löwik, C. W. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.02.005 · Cited by 367
The role of Axin2 in calvarial morphogenesis and craniosynostosis
Yu, H.-M. I., Jerchow, B., Sheu, T.-J., Liu, B., Costantini, F., Puzas, J. E., Birchmeier, W., & Hsu, W. (2005) · Development · doi:10.1242/dev.01786 · Cited by 357
Ellies, D. L., Viviano, B., McCarthy, J., Rey, J.-P., Itasaki, N., Saunders, S., & Krumlauf, R. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060810 · Cited by 350
Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6
Holmen, S. L., Giambernardi, T. A., Zylstra, C. R., Buckner-Berghuis, B. D., Resau, J. H., Hess, J. F., Glatt, V., Bouxsein, M. L., Ai, M., Warman, M. L., et al. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040907 · Cited by 344
Luo, Q., Kang, Q., Si, W., Jiang, W., Park, J. K., Peng, Y., Li, X., Luu, H. H., Luo, J., Montag, A. G., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407810200 · Cited by 319
Self-citationNoncanonical Wnt Signaling through G Protein-Linked PKCδ Activation Promotes Bone Formation
Tu, X., Joeng, K. S., Nakayama, K. I., Nakayama, K., Rajagopal, J., Carroll, T. J., McMahon, A. P., & Long, F. (2007) · Developmental Cell · doi:10.1016/j.devcel.2006.11.003 · Cited by 311
Zhang, J., Tu, Q., Bonewald, L. F., He, X., Stein, G., Lian, J., & Chen, J. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.377 · Cited by 289
Self-citationWnt10b Increases Postnatal Bone Formation by Enhancing Osteoblast Differentiation
Bennett, C. N., Ouyang, H., Ma, Y. L., Zeng, Q., Gerin, I., Sousa, K. M., Lane, T. F., Krishnan, V., Hankenson, K. D., & MacDougald, O. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070810 · Cited by 281
Kamiya, N., Ye, L., Kobayashi, T., Mochida, Y., Yamauchi, M., Kronenberg, H. M., Feng, J. Q., & Mishina, Y. (2008) · Development · doi:10.1242/dev.025825 · Cited by 275
Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway
Takemaru, K.-I., Yamaguchi, S., Lee, Y. S., Zhang, Y., Carthew, R. W., & Moon, R. T. (2003) · Nature · doi:10.1038/nature01570 · Cited by 274
Si, W., Kang, Q., Luu, H. H., Park, J. K., Luo, Q., Song, W.-X., Jiang, W., Luo, X., Li, X., Yin, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2955-2964.2006 · Cited by 272 · cited 1×
“Studies have demonstrated that Wnt signaling and the BMP signaling pathways have common targets which induce the osteogenic differentiation of MSCs; one such target is connective growth tissue factor [Luo et al. 2004; Si et al. 2006].”
BackgroundSelf-citationKansara, M., Tsang, M., Kodjabachian, L., Sims, N. A., Trivett, M. K., Ehrich, M., Dobrovic, A., Slavin, J., Choong, P. F. M., Simmons, P. J., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37175 · Cited by 272
Ominsky, M. S., Li, C., Li, X., Tan, H. L., Lee, E., Barrero, M., Asuncion, F. J., Dwyer, D., Han, C.-Y., Vlasseros, F., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.307 · Cited by 264
Ai, M., Holmen, S. L., Van Hul, W., Williams, B. O., & Warman, M. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.4946-4955.2005 · Cited by 253
Heath, D. J., Chantry, A. D., Buckle, C. H., Coulton, L., Shaughnessy, J. D., Evans, H. R., Snowden, J. A., Stover, D. R., Vanderkerken, K., & Croucher, P. I. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081104 · Cited by 243
Planar Cell Polarity Signaling: The Developing Cell's Compass
Vladar, E. K., Antic, D., & Axelrod, J. D. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002964 · Cited by 241
Wnt signaling as a therapeutic target for bone diseases
Hoeppner, L. H., Secreto, F. J., & Westendorf, J. J. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902841961 · Cited by 237
Li, X., Warmington, K. S., Niu, Q.-T., Asuncion, F. J., Barrero, M., Grisanti, M., Dwyer, D., Stouch, B., Thway, T. M., Stolina, M., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.182 · Cited by 231
Deregowski, V., Gazzerro, E., Priest, L., Rydziel, S., & Canalis, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508370200 · Cited by 231
Tang, N., Song, W., Luo, J., Luo, X., Chen, J., Sharff, K. A., Bi, Y., He, B., Huang, J., Zhu, G., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00569.x · Cited by 230
Self-citationLRP5 Mutations Linked to High Bone Mass Diseases Cause Reduced LRP5 Binding and Inhibition by SOST
Semenov, M. V., & He, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609509200 · Cited by 222
Lithium's effect on bone mineral density
Zamani, A., Omrani, G. R., & Nasab, M. M. (2009) · Bone · doi:10.1016/j.bone.2008.10.001 · Cited by 214
Heiland, G. R., Zwerina, K., Baum, W., Kireva, T., Distler, J. H., Grisanti, M., Asuncion, F., Li, X., Ominsky, M., Richards, W., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132852 · Cited by 208
Notch Inhibits Osteoblast Differentiation and Causes Osteopenia
Zanotti, S., Smerdel-Ramoya, A., Stadmeyer, L., Durant, D., Radtke, F., & Canalis, E. (2008) · Endocrinology · doi:10.1210/en.2008-0140 · Cited by 202
Clarke, B. L. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79307-2 · Cited by 200
Kamiya, N., Kobayashi, T., Mochida, Y., Yu, P. B., Yamauchi, M., Kronenberg, H. M., & Mishina, Y. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090806 · Cited by 198
β-Catenin Signaling Pathway Is Crucial for Bone Morphogenetic Protein 2 to Induce New Bone Formation
Chen, Y., Whetstone, H. C., Youn, A., Nadesan, P., Chow, E. C. Y., Lin, A. C., & Alman, B. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m602700200 · Cited by 192
Notch 1 Impairs Osteoblastic Cell Differentiation
Sciaudone, M., Gazzerro, E., Priest, L., Delany, A. M., & Canalis, E. (2003) · Endocrinology · doi:10.1210/en.2003-0463 · Cited by 192
Association between wild type and mutant APC gene products.
Su, L., Johnson, K. A., Smith, K. J., HILL, D. E., Vogelstein, B., & Kinzler, K. W. (1993) · PubMed · Cited by 191
Mak, K. K., Chen, M.-H., Day, T. F., Chuang, P.-T., & Yang, Y. (2006) · Development · doi:10.1242/dev.02546 · Cited by 191
Mechanisms Underlying the Osteo- and Adipo-Differentiation of Human Mesenchymal Stem Cells
Zhang, Y., Khan, D., Delling, J., & Tobiasch, E. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/793823 · Cited by 184
Kulkarni, N. H., Onyia, J. E., Zeng, Q., Tian, X., Liu, M., Halladay, D. L., Frolik, C. A., Engler, T., Wei, T., Kriauciunas, A., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060316 · Cited by 182
Pai, R., Tarnawski, A. S., & Tran, T. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0894 · Cited by 182
GSK-3β Controls Osteogenesis through Regulating Runx2 Activity
Kugimiya, F., Kawaguchi, H., Ohba, S., Kawamura, N., Hirata, M., Chikuda, H., Azuma, Y., Woodgett, J. R., Nakamura, K., & Chung, U. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000837 · Cited by 172
Kokubu, C., Heinzmann, U., Kokubu, T., Sakai, N., Kubota, T., Kawai, M., Wahl, M. B., Galceran, J., Grosschedl, R., Ozono, K., et al. (2004) · Development · doi:10.1242/dev.01405 · Cited by 169
Bone mass is inversely proportional to Dkk1 levels in mice
MacDonald, B. T., Joiner, D. M., Oyserman, S. M., Sharma, P., Goldstein, S. A., He, X., & Hauschka, P. V. (2007) · Bone · doi:10.1016/j.bone.2007.05.009 · Cited by 169
Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases
Sugimura, R., & Li, L. (2010) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20195 · Cited by 168
Human sebaceous tumors harbor inactivating mutations in LEF1
Takeda, H., Lyle, S. R., Lazar, A. J., Zouboulis, C. C., Smyth, I., & Watt, F. M. (2006) · Nature Medicine · doi:10.1038/nm1386 · Cited by 167
Stevens, J. R., Miranda-Carboni, G. A., Singer, M. A., Brugger, S. M., Lyons, K. M., & Lane, T. F. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.118 · Cited by 165
miR-27 promotes osteoblast differentiation by modulating Wnt signaling
Wang, T., & Xu, Z. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.031 · Cited by 165
Edwards, C. M., Edwards, J. R., Lwin, S. T., Esparza, J., Oyajobi, B. O., McCluskey, B., Munoz, S., Grubbs, B., & Mundy, G. R. (2008) · Blood · doi:10.1182/blood-2007-03-077685 · Cited by 160
Bodine, P. V. N., Stauffer, B., Ponce‐de‐Leon, H., Bhat, R. A., Mangine, A., Seestaller‐Wehr, L., Moran, R. A., Billiard, J., Fukayama, S., Komm, B. S., et al. (2009) · Bone · doi:10.1016/j.bone.2009.02.013 · Cited by 142
The WNT/Calcium pathway: biochemical mediators, tools and future requirements
Kühl, M. (2004) · Frontiers in bioscience · doi:10.2741/1307 · Cited by 140
Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
Rubin, E. M., Guo, Y., Tu, K., Xie, J., Zi, X., & Hoang, B. H. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0147 · Cited by 135
DKK1 Antagonizes Wnt Signaling without Promotion of LRP6 Internalization and Degradation
Semënov, M. V., Zhang, X., & He, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800014200 · Cited by 133
Gaur, T., Rich, L., Lengner, C. J., Hussain, S., Trevant, B., Ayers, D. C., Stein, J. L., Bodine, P. V. N., Komm, B. S., Stein, G. S., et al. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20637 · Cited by 130
Rosen, E. Y., Wexler, E. M., Versano, R., Coppola, G., Gao, F., Winden, K. D., Oldham, M. C., Martens, L. H., Zhou, P., Farese, R. V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.021 · Cited by 128
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
Li, X., Grisanti, M. S., Fan, W., Asuncion, F., Tan, H., Dwyer, D., Han, C.-Y. E., Yu, L., Lee, J. W., Lee, E., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.472 · Cited by 128
Axin2 controls bone remodeling through the β-catenin–BMP signaling pathway in adult mice
Yan, Y., Tang, D., Chen, M., Huang, J. H., Xie, R., Jonason, J. H., Tan, X., Hou, W., Reynolds, D., Hsu, W., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.051904 · Cited by 128
Feng, J. Q., Guo, F., Jiang, B., Zhang, Y., Frenkel, S. R., Wang, D., Tang, W., Xie, Y., & Liu, C.-J. (2010) · The FASEB Journal · doi:10.1096/fj.09-144659 · Cited by 122
Reduced Relative Risk of Fractures Among Users of Lithium
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0258-y · Cited by 121
Modulation of Wnt signaling influences fracture repair
Komatsu, D. E., Mary, M. N., Schroeder, R. J., Robling, A. G., Turner, C. H., & Warden, S. J. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21078 · Cited by 119
LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders
Levasseur, R., Lacombe, D., & de Vernejoul, M. C. (2004) · Joint Bone Spine · doi:10.1016/j.jbspin.2004.10.008 · Cited by 119
MicroRNAs: Synthesis, Gene Regulation and Osteoblast Differentiation
Vimalraj, S., & Selvamurugan, N. (2013) · Current Issues in Molecular Biology · doi:10.21775/cimb.015.007 · Cited by 111
Liu, Z., Tang, Y., Qiu, T., Cao, X., & Clemens, T. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513812200 · Cited by 111
Glantschnig, H., Hampton, R. A., Lü, P., Zhao, J. Z., Vitelli, S., Huang, L., Haytko, P., Cusick, T. E., Ireland, C., Jarantow, S. W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166892 · Cited by 109
Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis
Iwaya, K., Ogawa, H., Kuroda, M., Izumi, M., Ishida, T., & Mukai, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1025821229013 · Cited by 107
Balemans, W., Devogelaer, J., Cleiren, E., Piters, E., Caussin, E., & Hul, W. V. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070211 · Cited by 101
Wang, K., Zhang, Y., Li, X., Chen, L., Wang, H., Wu, J., Zheng, J., & Wu, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802376200 · Cited by 99
Zhang, M., Yan, Y., Lim, Y., Tang, D., Xie, R., Chen, A., Tai, P., Harris, S. E., Xing, L., Qin, Y., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22319 · Cited by 95
β‐Catenin—A supporting role in the skeleton
Case, N. D., & Rubin, J. E. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22574 · Cited by 92
Glantschnig, H., Scott, K., Hampton, R. A., Wei, N., McCracken, P. J., Nantermet, P. V., Zhao, J. Z., Vitelli, S., Huang, L., Haytko, P., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181404 · Cited by 88
Dkk1 Stabilizes Wnt Co-Receptor LRP6: Implication for Wnt Ligand-Induced LRP6 Down-Regulation
Li, Y., Lü, W., King, T. D., Liu, C., Bijur, G. N., & Bu, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011014 · Cited by 85
Kubota, T., Michigami, T., Sakaguchi, N., Kokubu, C., Suzuki, A., Namba, N., Sakai, N., Nakajima, S., Imai, K., & Ozono, K. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080512 · Cited by 80
Gambardella, A., Nagaraju, C. K., O'Shea, P. J., Mohanty, S. T., Kottam, L., Pilling, J. E., Sullivan, M., Djerbi, M., Koopmann, W., Croucher, P. I., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.266 · Cited by 79
The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Wagner, E. R., Zhu, G., Zhang, B., Luo, Q., Shi, Q., Huang, E., Gao, Y., Gao, J., Kim, S. H., Rastegar, F., et al. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104010014 · Cited by 78
Self-citationKulkarni, N. H., Wei, T., Kumar, A., Dow, E. R., Stewart, T. R., Shou, J., N'Cho, M., Sterchi, D. L., Gitter, B. D., Higgs, R. E., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21374 · Cited by 71
Qian, J., Zheng, Y., Zheng, C., Wang, L., Qin, H., Hong, S., Li, H., Lu, Y., He, J., Yang, J., et al. (2011) · Blood · doi:10.1182/blood-2011-07-368472 · Cited by 70
Noh, T., Gabet, Y., Cogan, J. P., Shi, Y., Tank, A., Sasaki, T., Criswell, B., Dixon, A., Lee, C. S., Tam, J., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005438 · Cited by 69
Secreted frizzled related protein 1 is a target to improve fracture healing
Gaur, T., Wixted, J. J., Hussain, S., O’Connell, S. L., Morgan, E. F., Ayers, D. C., Komm, B. S., Bodine, P. V. N., Stein, G. S., & Lian, J. B. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21747 · Cited by 69
Nemoto, E., Ebe, Y., Kanaya, S., Tsuchiya, M., Nakamura, T., Tamura, M., & Shimauchi, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.039 · Cited by 65
Dartigues, P., El-Bchiri, J., Krimi, A., Buhard, O., Fontanges, P., Fléjou, J., Hamelin, R., & Duval, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209471 · Cited by 65
Chibby Promotes Adipocyte Differentiation through Inhibition of β-Catenin Signaling
Li, F., Singh, A. M., Mofunanya, A., Love, D. K., Terada, N., Moon, R. T., & Takemaru, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01640-06 · Cited by 65
Agholme, F., Isaksson, H., Kuhstoss, S. A., & Aspenberg, P. (2011) · Bone · doi:10.1016/j.bone.2011.02.008 · Cited by 64
The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Wagner, E. R., Zhu, G., Zhang, B., et al. (2011) · Current Molecular Pharmacology · doi:10.2174/1874467211104010014 · Cited by 64
Lithium use and the risk of fractures
Wilting, I., de Vries, F., Thio, B., Cooper, C. C., Heerdink, E. R., Leufkens, H. G. M., Nolen, W. A., Egberts, T. C. G., & van Staa, T. P. (2006) · Bone · doi:10.1016/j.bone.2006.12.055 · Cited by 61
Miclea, R. L., Karperien, M., Bosch, C. A. J., van der Horst, G., van der Valk, M. A., Kobayashi, T., Kronenberg, H. M., Rawadi, G., Akçakaya, P., Löwik, C. W. G. M., et al. (2009) · BMC Developmental Biology · doi:10.1186/1471-213x-9-26 · Cited by 59
Moore, W., Kern, J. C., Bhat, R. A., Commons, T. J., Fukayama, S., Goljer, I., Krishnamurthy, G., Magolda, R. L., Nogle, L. M., Pitts, K. E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801144h · Cited by 57
Wexler, E. M., Rosen, E., Lu, D., Osborn, G. E., Martin, E., Raybould, H., & Geschwind, D. H. (2011) · Science Signaling · doi:10.1126/scisignal.2002282 · Cited by 56
Riancho, J. A., Olmos, J. M., Pineda, B., García‐Ibarbia, C., Pérez‐Núñez, M. I., Nan, D., Montes, J. V., Cano, A., García‐Pérez, M. Á., Zarrabeitia, M. T., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0582 · Cited by 56
Huang, Q.-Y., Li, G. H., & Kung, A. W. C. (2009) · Bone · doi:10.1016/j.bone.2009.03.676 · Cited by 52
Inhibition of SFRP1 Reduces Severity of Periodontitis
Li, C. H., & Amar, S. (2007) · Journal of Dental Research · doi:10.1177/154405910708600913 · Cited by 51
Axin2 regulates chondrocyte maturation and axial skeletal development
Dao, D. Y., Yang, X. L., Flick, L. M., Chen, D., Hilton, M. J., & O’Keefe, R. J. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20954 · Cited by 51
Agholme, F., Isaksson, H., Li, X., Ke, H. Z., & Aspenberg, P. (2011) · Acta Orthopaedica · doi:10.3109/17453674.2011.625539 · Cited by 29
B563 Anti-DKK1 mAb (BHQ880) as a Potential Therapeutic Agent for Multiple Myeloma
Fulciniti, M., Vallet, S., Ettenberg, S. A., Shen, X., Raje, N. S., Tassone, P., Hideshima, T., Nanjappa, P., PRABHALA, R. H., Anderson, K. C., et al. (2009) · Clinical Lymphoma & Myeloma · doi:10.1016/s1557-9190(11)70775-2 · Cited by 28
Moore, W., Kern, J. C., Bhat, R. A., Bodine, P. V. N., Fukyama, S., Krishnamurthy, G., Magolda, R. L., Pitts, K. E., Stauffer, B., & Trybulski, E. J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.11.002 · Cited by 25
Cited by
Liao, J., Wei, Q., Zou, Y., Fan, J., Song, D., Cui, J., Zhang, W., Zhu, Y., Ma, C., Hu, X., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471945 · Cited by 2,742
Self-citationTGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation
Rahman, M. S., Akhtar, N., Jamil, H. M., Banik, R. S., & Asaduzzaman, S. M. (2015) · Bone Research · doi:10.1038/boneres.2015.5 · Cited by 587
Wnt Pathway in Bone Repair and Regeneration – What Do We Know So Far
Houschyar, K. S., Tapking, C., Borrelli, M. R., Popp, D., Duscher, D., Maan, Z. N., Chelliah, M. P., Li, J., Harati, K., Wallner, C., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00170 · Cited by 295
Clay nanoparticles for regenerative medicine and biomaterial design: A review of clay bioactivity
Mousa, M., Evans, N. D., Oreffo, R. O. C., & Dawson, J. I. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.024 · Cited by 286
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
Self-citation
Metadata
- Authors
- Kim, J. H., Liu, X., Wang, J., Chen, X., Zhang, H., Kim, S. H., Cui, J., Li, R., Zhang, W., Kong, Y., Zhang, J., Shui, W., Lamplot, J., Rogers, M. R., Zhao, C., Wang, N., Rajan, P., Tomal, J., Statz, J., Wu, N., Luu, H. H., Haydon, R. C., & He, T.-C.
- Venue
- Therapeutic Advances in Musculoskeletal Disease
- Publisher
- SAGE Publications
- Published
- 2013-02
- Volume
- 5
- Issue
- 1
- Pages
- 13-31
- ISSN
- 1759-720X (ISSN-L)
- 1759-7218
- OpenAlex
- W2064720410
- Cited by
- 356
- References
- 156
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.